Literature DB >> 2762215

Drug binding to alpha 1-acid glycoprotein studied by circular dichroism.

M Otagiri1, R Yamamichi, T Maruyama, T Imai, A Suenaga, Y Imamura, K Kimachi.   

Abstract

The interactions of acidic and basic drugs with alpha 1-acid glycoprotein (alpha 1-AGP) were investigated using circular dichroism (CD) measurements. Extrinsic Cotton effects were generated by the binding of drugs to alpha 1-AGP. The CD data suggested the presence of a single binding site on the alpha 1-AGP molecule. The induced ellipticities of the acidic drug-alpha 1-AGP system decreased with increasing pH, while the ellipticities for the basic drugs increased with pH. The ellipticities for all drugs were reduced by the addition of fatty acids. Furthermore, the induced ellipticities decreased in the presence of cesium chloride for basic drugs bound to alpha 1-AGP. The extrinsic Cotton effects therefore appear to result from hydrophobic interaction with alpha 1-AGP for the acidic drugs and from hydrophobic and electrostatic interactions for the basic drugs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2762215     DOI: 10.1023/a:1015936710919

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  13 in total

1.  Fluorescent investigations of binding of phenprocoumon to alpha 1-acid glycoprotein.

Authors:  M Otagiri; T Maruyama; T Imai; Y Imamura
Journal:  J Pharm Sci       Date:  1987-08       Impact factor: 3.534

2.  [Specific binding of perazine, a piperazine side-chain phenothiazine drug, to a serum protein (author's transl)].

Authors:  J Schley; M Nündel; E Riedel; B Müller-Oerlinghausen
Journal:  Arzneimittelforschung       Date:  1979

3.  The plasma protein binding of basic drugs.

Authors:  P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

4.  Interactions of benzodiazepines with human serum albumin. Circular dichroism studies.

Authors:  W Müller; U Wollert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Binding of several phenothiazine neuroleptics to a common binding site of alpha 1-acid glycoprotein, orosomucoid.

Authors:  S El-Gamal; U Wollert; W E Müller
Journal:  J Pharm Sci       Date:  1983-02       Impact factor: 3.534

6.  A comparative study of the interaction of warfarin with human alpha 1-acid glycoprotein and human albumin.

Authors:  M Otagiri; T Maruyama; T Imai; A Suenaga; Y Imamura
Journal:  J Pharm Pharmacol       Date:  1987-06       Impact factor: 3.765

7.  Conformational changes in human serum albumin around the neutral pH from circular dichroic measurements.

Authors:  J Wilting; M M Weideman; A C Roomer; J H Perrin
Journal:  Biochim Biophys Acta       Date:  1979-08-28

8.  Fluorescence quenching of human orosomucoid. Accessibility to drugs and small quenching agents.

Authors:  M L Friedman; K T Schlueter; T L Kirley; H B Halsall
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

9.  The role of albumin conformation in the binding of diazepam to human serum albumin.

Authors:  J Wilting; B J Hart; J J De Gier
Journal:  Biochim Biophys Acta       Date:  1980-12-16

10.  Evidence for binding of certain acidic drugs to alpha 1-acid glycoprotein.

Authors:  S Urien; E Albengres; R Zini; J P Tillement
Journal:  Biochem Pharmacol       Date:  1982-11-15       Impact factor: 5.858

View more
  2 in total

1.  Reversal of signs of induced cotton effects of dicumarol-alpha 1-acid glycoprotein systems by phenothiazine neuroleptics through ternary complexation.

Authors:  T Miyoshi; R Yamamichi; T Maruyama; M Otagiri
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

2.  Drug-binding energetics of human α-1-acid glycoprotein assessed by isothermal titration calorimetry and molecular docking simulations.

Authors:  Johnny X Huang; Matthew A Cooper; Mark A Baker; Mohammad A K Azad; Roger L Nation; Jian Li; Tony Velkov
Journal:  J Mol Recognit       Date:  2012-12       Impact factor: 2.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.